2019 ABC Summer Summit and MD Workshop

Agenda

At-A-Glance
2-Day Summer (Tue-Thu)
2-Day Medical (Tue-Wed)
1-Day Medical (Tue)
1-Day Summer (Wed)
Reception (Wed)

  Go
    • Monday, 07/29/19
    •  
      8:00 AM  -  6:30 PM
      BCA MD Workshop & Reception (separate registration)
      contact BCA for registration
      12:00 PM  -  5:00 PM
      ADRP Board Meeting (invitation only)
    • Tuesday, 07/30/19
    •  
      7:00 AM  -  8:00 AM
      Registration & Continental Breakfast
      8:00 AM  -  5:00 PM
      ADRP Board Meeting (invitation only)
      8:00 AM  -  8:05 AM
      MD WORKSHOP: Welcome & Introductions
      8:05 AM  -  9:35 AM
      Emergency Transfusions Outside the Hospital

      • Understand the regulatory requirements necessary to provide blood components to emergency service      providers
      • Understand the complexities for a blood center to function as a transfusion service for emergency service providers
      • Understand remote damage control resuscitation and the importance of blood components in these protocols

      • Review the products commonly available for emergent transfusion
      • Explore recent research findings and practice changes concerning emergent transfusion
      • Consider pros and cons of transfusion outside the hospital

      9:35 AM  -  9:50 AM
      Q & A
      9:50 AM  -  10:10 AM
      Break
      10:10 AM  -  11:00 AM
      Obstetric Hemorrhage
      • Define massive transfusion in the obstetrical setting
      • Detail risk factors for massive transfusion in the obstetric patient
      • Discuss the use of massive transfusion protocols in managing obstetric hemorrhage
      Speakers:
      11:00 AM  -  11:10 AM
      Q & A
      11:10 AM  -  11:55 AM
      Are you preparing for PrEP?
      • Understand what PrEP is
      • Understand data on the efficacy of PrEP
      • Understand the possible impact of PrEP and antiretroviral therapy in the donor room
      Speakers:
      11:55 AM  -  12:05 PM
      Q & A
      12:00 PM  -  5:00 PM
      ABC Board Meeting (members only)
      attendance restricted to ABC/EBA members
      12:05 PM  -  1:30 PM
      Committee Lunch - SMT
      attendance restricted to ABC/EBA members
      12:05 PM  -  1:30 PM
      Lunch
      1:30 PM  -  2:45 PM
      Medical Director Organizational Value/Effects of Blood Center Consolidation on Medical Directors

      Business Value of the Blood Center Physician
      Laurie J. Sutor, MD, MBA
      • List ways in which the blood center physician can
        contribute to the organization's bottom line
      • Understand how the medical director can
        successfully contribute to the business
        operations and management of the blood center
      • Analyze ways for the blood center physician to help look
        for new revenue streams.

      Moving from Value Based to Revenue Generating
      Physician Services
      Richard Gammon, MD
      • Be knowledgeable of opportunities for revenue
        generating consulting 
      • Determine whether a physician-run outpatient
        clinic is a "good fit" for your current blood 
        center model 
      • Learn how to "make the ask" for fee-based
        services

      Effects of Blood Center Consolidation on
      Medical Directors
      Samantha Mack, MD
      • Determine whether a physician-run outpatient
        clinic is a "good fit" for your current blood 
        center model 
      • List ways in which the blood center physician
        can contribute to the organization's
        bottom line
      • Understand the short-term and long-term
        impact of consolidation of a "local, regional"
        blood center into a national blood provider
        on the medical director's role


      2:45 PM  -  3:15 PM
      Novel Strategies to Improve NK cell Immunotherapy
      • Understand the emerging concept of adaptive NK cells with properties of immune memory.
      • Understand how the CD16 activating receptor can be repurposed to make NK cells antigen specific
      • Understand concepts of off the shelf induced pluripotent derived NK cells
      3:15 PM  -  3:25 PM
      Q & A
      3:25 PM  -  3:40 PM
      Break
      3:40 PM  -  4:20 PM
      TEG/ROTEM In Transfusion Management
      • Describe the mechanism of TEG/ROTEM
      • List expected TEG/ROTEM parameters in coagulopathic versus bleeding patient
      • Explain limitations of TEG/ROTEM in cirrhotic patients
      Speakers:
      4:20 PM  -  4:35 PM
      Q & A
      4:35 PM  -  5:20 PM
      Morbidity and Mortality Rounds
      • Review case studies prepared by participants for review and discussion by the audience
      5:30 PM  -  7:00 PM
      MD Workshop Reception
      6:30 PM  -  8:30 PM
      ABC Board/Past Presidents Dinner (invitation only)
      off-site
    • Wednesday, 07/31/19
    •  
      7:30 AM  -  8:30 AM
      Registration & Continental Breakfast
      8:30 AM  -  8:50 AM
      SUMMER SUMMIT: Overview and Purpose of the Day
      8:50 AM  -  10:10 AM
      Innovation Area 1 – Donor/Community Engagement

      8:50 – 9:20 a.m. The Next Big Trends in
      Customer Experience
      Rick Parrish, Principal
      Customer Experience
      Analyst, Forrester
      Research

      9:20 – 9:50 a.m. Building a Strategic Plan to Increase Minority Blood Donations
      Ashley Singleton, MPH, Research
      Associate, Georgia Health Policy
      Center

      • Develop a strategic plan to
        increase minority blood
        donations.
      • Communicate barriers to
        MBD and potential solutions.
      • Identify innovative strategies
        that fit their local communities.


      9:50 – 10:10 a.m. Member Feedback and Q & A

      10:10 AM  -  10:25 AM
      Break
      10:25 AM  -  12:10 PM
      Innovation Area 2 – Positioning and Diversification through Products & Services

      10:25 – 10:55 a.m. The Intersection of
      Innovation and Research
      Dana Devine, PhD, MA, Chief
      Scientist, Canadian Blood Services

      • The value of a development
        laboratory to a blood service. 
      • An understanding of the 
        innovation pipeline as applied 
        to public sector organizations. 
      • The role of blood product focused
        researchers in assisting with
        problem solving in routine
        operations.

      10:55 – 11:25 a.m. Driving Innovation through 
      Research
      Philip Norris, MD, VP, Research
      Vitalant Research Institute

      • New evolving threats to 
        blood safety 
      • What's in the bag besides
        red blood cells or platelets 
      • What manufacturing innovation
        should we expect

      11:25 – 11:55 a.m. So much to discover, so little
      time - High throughput Omics
      and Red Blood Cell Storage
      Angelo D'Alessandro, PhD, Assistant Professor, CU Anschutz Medical Campus

      11:55 – 12:10 p.m. Member Feedback and Q & A


       
      12:10 PM  -  1:10 PM
      Lunch
      1:10 PM  -  2:10 PM
      Innovation Area 3 – Data & Digital

      1:10 – 2:10 p.m. Today's Digital Imperative
      in Healthcare
      Eric Langshur, Managing
      Partner, Adventure
      Venture Partners

      • Evidence based support
        for digital impact
      • Strategies to leverage
        digital tools
      • Measurement approaches
        to build business case for
        investment in digital
      Speakers:
      2:10 PM  -  3:25 PM
      Innovation Area 4 – Removing Barriers to Innovation

      2:10 – 2:40 p.m. FDA's Approach to Risk and Benefit
      Consideration for the Blood Supply
      Peter Marks, MD, PhD Director,
      Center for Biologics Evaluation and
      Research, U.S. Food and Drug
      Administration
      • Review existing deferral policies
      • Discuss impact of novel
         technologies on blood safety
      • Explore potential policy
         implications

      2:40 – 3:10 p.m. A New Frontier: 
      Emerging Products and Services
      Andrew P. Cap, MD, PhD, Chief,
      Blood Research US Army Institute 
      of Surgical Research 

      3:10 – 3:40 p.m. Pathway to Approval
      OneBlood's Experience with
      Non-Invasive Hemoglobin
      Screening
      Rita Reik, MD, Chief Medical
      Officer, America's Blood Centers
      Medical Director, OneBlood
        Describe the regulatory pathway for licensing of the OrSense NBM 200 non-invasive Hgb device 
      • Discuss the innovative aspects of non-invasive Hgb measurement


      3:40 – 3:55 p.m. Member Feedback and Q & A

      3:55 PM  -  4:10 PM
      Break
      4:10 PM  -  5:10 PM
      Roundtables and Consensus Development
      5:30 PM  -  7:00 PM
      Summit Reception
    • Thursday, 08/01/19
    •  
      7:00 AM  -  8:00 AM
      Continental Breakfast
      7:00 AM  -  9:00 AM
      Policy Council Breakfast
      9:00 AM  -  11:30 AM
      MEMBERS MEETING (members only)
      attendance restricted to ABC/EBA members
      12:00 PM  -  2:30 PM
      Women-Inspiring-Leading-Learning High Tea Luncheon
      Sponsored by: Terumo BCT
    Top